Clinical features of spinal muscular atrophy (SMA) type 2

被引:0
|
作者
Cances, C. [1 ]
Richelme, C. [2 ]
Barnerias, C. [3 ]
Espil, C. [4 ]
机构
[1] Toulouse Univ Hosp, Neuropaediat Dept, AOC Atlantique Occitante Caraibe Reference Ctr Ne, Toulouse, France
[2] Hop Pediat Nice CHU Lenval, CMR Neuromusculaire PACARARE, Nice, France
[3] CMR Neuromusculaire NEIDF, AP HP, Paris, France
[4] CHU Bordeaux, Hop Enfants, CMR Neuromusculaire AOC, Bordeaux, France
来源
ARCHIVES DE PEDIATRIE | 2020年 / 27卷 / 07期
关键词
Spinal muscular atrophy type 2; Diagnosis semiology; Clinical evolution; PROSPECTIVE COHORT; MUSCLE STRENGTH; MOTOR FUNCTION; NUSINERSEN; CHILDREN; SURVIVAL; ADULTS;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Infantile spinal muscular atrophy (SMA) type 2 is sometimes called intermediate SMA to indicate the disease severity. Generally, psychomotor development is normal until the age of 6 to 8 months, with the acquisition of a stable sitting position. The early signs are muscle weakness, mostly affecting the lower limbs, generalized hypotonia and areflexia. The consequences of motor neuron degeneration are functional and orthopaedic, respiratory, nutritional, socio-professional, and psychological. The implementation of standardized care (i.e., standard of care recommendations) has improved the quality of life and survival outcome of patients. The emergence of innovative therapies, some of which are now available, should further improve the clinical evolution of this disease. (C) 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [21] Safety update: Risdiplam clinical trial program for spinal muscular atrophy (SMA)
    Baranello, G.
    Chiriboga, C.
    Servais, L.
    Darras, B.
    Day, J.
    Deconinck, N.
    Farrar, M.
    Finkel, R.
    Bertini, E.
    Kirschner, J.
    Rasson, M.
    Mazurkiewicz-Beldzinska, M.
    Vlodavets, D.
    Bader-Weder, S.
    Gorni, K.
    Jaber, B.
    Yeung, W.
    Papp, G.
    Scalco, R.
    Mercuri, E.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S92 - S93
  • [22] Clinical and electrophysiological evaluation of fatigue in adult patients with spinal muscular atrophy (SMA)
    Iwabe, C.
    Franco da Graca, F.
    Nucci, A.
    Franca, M., Jr.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S88 - S88
  • [23] Clinical features of adult spinal muscular atrophy:46 cases
    Xiaojun He1
    2Department of Pathology
    3Department of Neurology
    NeuralRegenerationResearch, 2006, (01) : 94 - 96
  • [24] Correlation of clinical and molecular features in spinal bulbar muscular atrophy
    Fratta, Pietro
    Nirmalananthan, Niranjanan
    Masset, Luc
    Skorupinska, Iwona
    Collins, Toby
    Cortese, Andrea
    Pemble, Sally
    Malaspina, Andrea
    Fisher, Elizabeth M. C.
    Greensmith, Linda
    Hanna, Michael G.
    NEUROLOGY, 2014, 82 (23) : 2077 - 2084
  • [25] Clinical and molecular genetic features of congenital spinal muscular atrophy
    Devriendt, K
    Lammens, M
    Schollen, E
    VanHole, C
    Dom, R
    Devlieger, H
    Cassiman, JJ
    Fryns, JP
    Matthijs, G
    ANNALS OF NEUROLOGY, 1996, 40 (05) : 731 - 738
  • [26] COST OF SPINAL MUSCULAR ATROPHY(SMA) MANAGEMENT IN TURKIYE
    Ozturk, F.
    Okcun, S.
    Tibet, B.
    Kockaya, G.
    VALUE IN HEALTH, 2023, 26 (12) : S146 - S147
  • [27] INDIRECT COST OF SPINAL MUSCULAR ATROPHY (SMA) IN SINGAPORE
    Lim, Z. Z.
    Tay, S.
    Wang, F.
    Ling, S.
    Lim, Y. L.
    Wang, Y.
    VALUE IN HEALTH, 2023, 26 (12) : S98 - S98
  • [28] Carrier detection of spinal muscular atrophy (SMA) in Iran
    Najmabadi, H
    Teimourian, S
    Pourfarzad, F
    Kariminejad, R
    Shafeghati, Y
    Neishabury, M
    JOURNAL OF MEDICAL GENETICS, 2000, 37 : S83 - S83
  • [29] PTEN as therapeutic target for spinal muscular atrophy (SMA)
    Ning, K.
    Godena, V. K.
    Souza, C. Dos Santos
    Arya, S.
    Gillingwater, T. H.
    Talbot, K.
    Azzouz, M.
    HUMAN GENE THERAPY, 2019, 30 (08) : A26 - A26
  • [30] SPINAL MUSCULAR-ATROPHY (SMA) IN AFRICAN CHILDREN
    MOOSA, A
    DAWOOD, A
    MUSCLE & NERVE, 1986, 9 (05) : 119 - 119